On the stock market since 1994, it operates in the world of health and science. It has 6 employees. Now — the numbers.
The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.
An average decline of 45% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.
An investor who bought at the very peak is down 99% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
The company sells $332K a year; the problem isn’t sales — it’s costs running above that number.
A loss of $2.8M against $332K in annual sales.
The stock sits at $0.0001. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
On our five-subject report card, GRPS sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: GRPS is a small company that closed last year at a loss. The road back to profit runs through spending discipline.